Deferred Tax Assets, Valuation Allowance of Armata Pharmaceuticals, Inc. from 31 Dec 2013 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Armata Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2013 to 31 Dec 2024.
  • Armata Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $84,217,000, a 12% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Armata Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $84,217,000 +$9,051,000 +12% 31 Dec 2024 10-K 21 Mar 2025 2024 FY
Q4 2023 $75,166,000 +$6,348,000 +9.2% 31 Dec 2023 10-K 21 Mar 2025 2024 FY
Q4 2022 $68,818,000 +$10,567,000 +18% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q4 2021 $58,251,000 +$6,279,000 +12% 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q4 2020 $51,972,000 +$6,302,000 +14% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q4 2019 $45,670,000 +$9,552,000 +26% 31 Dec 2019 10-K 18 Mar 2021 2020 FY
Q4 2018 $36,118,000 -$11,393,000 -24% 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q4 2017 $47,511,000 -$24,173,000 -34% 31 Dec 2017 10-K 25 Mar 2019 2018 FY
Q4 2016 $71,684,000 +$676,000 +0.95% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q4 2015 $71,008,000 +$4,525,000 +6.8% 31 Dec 2015 10-K 27 Mar 2017 2016 FY
Q4 2014 $66,483,000 +$2,697,000 +4.2% 31 Dec 2014 10-K 30 Mar 2016 2015 FY
Q4 2013 $63,786,000 31 Dec 2013 10-K 15 Apr 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.